Table 1:
Author and year | Source | Detection | Genes | HPV subtype | Baseline Sensitivity |
---|---|---|---|---|---|
Chera et al. 2020 | Plasma | ddPCR | E6,E7 | Panel | -- |
Nguyen et al. 2020 | Plasma & EV | ddPCR | E7 | 16 | 91% & 42% |
Rutkowski et al. 2020 | Plasma | qPCR | E6, E7 | 16 | -- |
Damerla et al. 2019 | Plasma | ddPCR | E6, E7 | 16, 33 | 95.6% |
Chera et al. 2019 | Plasma | ddPCR | E7 | Panel | 89% |
Hanna et al. 2018 | Plasma | ddPCR | E7 | Panel | -- |
Lee et al. 2017 | Plasma | NGS | E7 | 16 | 95.7% |
Mazurek et al. 2016 | Plasma | qPCR | E6, E7 | 16, 18 | -- |
Jeannot et al. 2016 | Plasma and serum | ddPCR | E7 | 16, 18 | 100% |
Dahlstrom et al. 2015 | Serum | qPCR | E6, E7 | 16 | 60.5% |
Wang et al. 2015 | Saliva and plasma | PCR | E7 | 16, 18 | 86% |
Ahn et al. 2014 | Saliva and plasma | qPCR | E6, E7 | 16 | 76.1% |